Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation.
作者信息
Luber Verena, Lutz Mathias, Thiede Christian, Haferlach Claudia, Dürk Heinz Albert, Einsele Hermann, Grigoleit Götz Ulrich, Mielke Stephan
机构信息
Department of Internal Medicine II, University Hospital of Würzburg, Oberdürrbacher Str. 6, D-97080, Würzburg, Germany.
Department of Hematology and Oncology, Sana Hospital Hof, Eppenreuther Str. 9, D-95032, Hof, Germany.
出版信息
Ann Hematol. 2020 Apr;99(4):899-901. doi: 10.1007/s00277-020-03905-x. Epub 2020 Feb 22.
Abstract
摘要
相似文献
1
Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation.
Ann Hematol. 2020 Apr;99(4):899-901. doi: 10.1007/s00277-020-03905-x. Epub 2020 Feb 22.
2
Haploidentical unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT.
Haematologica. 2019 Mar;104(3):524-532. doi: 10.3324/haematol.2017.187450. Epub 2018 Oct 25.
3
T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Cancer. 2018 May 15;124(10):2142-2150. doi: 10.1002/cncr.31310. Epub 2018 Feb 22.
4
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.
5
TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Hematology. 2017 Apr;22(3):136-144. doi: 10.1080/10245332.2016.1238182. Epub 2016 Oct 10.
6
Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.
Eur J Haematol. 2012 Dec;89(6):497-500. doi: 10.1111/ejh.12017. Epub 2012 Oct 26.
7
Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.
Bone Marrow Transplant. 1998 Dec;22 Suppl 5:S29-32.
8
αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant. 2019 May;25(5):e179-e182. doi: 10.1016/j.bbmt.2019.01.023. Epub 2019 Jan 21.
9
Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
Ann Hematol. 2020 Dec;99(12):2911-2925. doi: 10.1007/s00277-020-04283-0. Epub 2020 Oct 1.
10
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
N Engl J Med. 1998 Oct 22;339(17):1186-93. doi: 10.1056/NEJM199810223391702.
引用本文的文献
1
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.
Bone Marrow Transplant. 2021 Jul;56(7):1535-1549. doi: 10.1038/s41409-021-01214-z. Epub 2021 Mar 8.
本文引用的文献
1
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.
Br J Haematol. 2019 Sep;186(5):754-766. doi: 10.1111/bjh.15970. Epub 2019 May 28.
2
The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.
Ann Hematol. 2019 Mar;98(3):541-559. doi: 10.1007/s00277-019-03606-0. Epub 2019 Jan 21.
3
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
Leukemia. 2019 Feb;33(2):508-517. doi: 10.1038/s41375-018-0218-6. Epub 2018 Jul 26.
4
Regulation of Malignant Hematopoiesis by Bone Marrow Microenvironment.
Front Oncol. 2018 Apr 23;8:119. doi: 10.3389/fonc.2018.00119. eCollection 2018.
5
Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis.
Leukemia. 2018 Aug;32(8):1822-1826. doi: 10.1038/s41375-018-0042-z. Epub 2018 Feb 5.
6
Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient.
Leukemia. 2017 Jul;31(7):1637-1640. doi: 10.1038/leu.2017.104. Epub 2017 Mar 28.
7
Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists.
Mol Cytogenet. 2016 Aug 8;9:62. doi: 10.1186/s13039-016-0275-3. eCollection 2016.
8
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Blood. 2011 May 12;117(19):5257-60. doi: 10.1182/blood-2010-12-326322. Epub 2011 Mar 14.
9
Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.
J Mol Diagn. 2010 Jul;12(4):530-7. doi: 10.2353/jmoldx.2010.090215. Epub 2010 Apr 29.
10
Development of original donor cell leukemia after successful engraftment from a second donor.
Blood. 2007 Dec 15;110(13):4621-2. doi: 10.1182/blood-2007-07-104240.
Zotero 插件